Ramautarsing, Reshmie A <br/><br/>
Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients.  [electronic resource] 

 -  Antiviral therapy  2013 
 - 249-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2040-2058 
<br/><br/><label>Standard No.: </label>10.3851/IMP2324  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--adverse effects<br/>CD4 Lymphocyte Count<br/>Drug Combinations<br/>Female<br/>Follow-Up Studies<br/>HIV Infections--drug therapy<br/>Humans<br/>Lopinavir--adverse effects<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Ritonavir--adverse effects<br/>Thailand<br/>Treatment Outcome<br/>Viral Load